{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:55:58Z","timestamp":1773924958256,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","award":["YX-2023\\u201302"],"award-info":[{"award-number":["YX-2023\\u201302"]}],"id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017720","name":"Kunming Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023\\u201313\\u201305\\u2013002"],"award-info":[{"award-number":["2023\\u201313\\u201305\\u2013002"]}],"id":[{"id":"10.13039\/100017720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","award":["202301AY070001\\u2013280"],"award-info":[{"award-number":["202301AY070001\\u2013280"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.arcped.2025.09.002","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:10:37Z","timestamp":1763165437000},"page":"105444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tacrolimus in pediatric patients with Henoch-Sch\u00f6nlein purpura nephritis: Target concentration range"],"prefix":"10.1016","volume":"33","author":[{"given":"Fashuang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1167-3943","authenticated-orcid":false,"given":"Huiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2025.09.002_bib0001","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.12998\/wjcc.v11.i26.6311","article-title":"Delayed diagnosis of abdominal Henoch-Sch\u00f6nlein purpura in children: a case report","volume":"11","author":"Guo","year":"2023","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.arcped.2025.09.002_bib0002","first-page":"271","article-title":"Clinical application of compound glycyrrhizin tablets in the treatment of patients with simplex Henoch-Sch\u00f6nlein purpura and its effect on immune function","volume":"38","author":"Li","year":"2022","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.arcped.2025.09.002_bib0003","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/jorc.12451","article-title":"A disease-targeted picture book for children with Henoch-Sch\u00f6nlein purpura nephritis: a quasi-experimental study","volume":"49","author":"Tang","year":"2023","journal-title":"J Renal Care"},{"key":"10.1016\/j.arcped.2025.09.002_bib0004","first-page":"259","article-title":"Changes of peripheral blood lymphocyte subsets and immune function in children with Henoch-Sch\u00f6nlein purpura nephritis","volume":"18","author":"Su","year":"2021","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.arcped.2025.09.002_bib0005","first-page":"647","article-title":"Pediatrics Society of Chinese Medical Association. Diagnosis and treatment of purpura nephritis Syndrome guidelines (2016)","volume":"55","year":"2017","journal-title":"Chin J Pediatr"},{"key":"10.1016\/j.arcped.2025.09.002_bib0006","first-page":"563","article-title":"Henoch-Sch\u00f6nlein purpura nephritis in children","volume":"10","author":"Davin","year":"2014","journal-title":"Nat V Nephuol"},{"key":"10.1016\/j.arcped.2025.09.002_bib0007","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12519-014-0534-5","article-title":"Henoch-Sch\u00f6nlein purpura nephritis in children: incidence, pathogenesis and management","volume":"11","author":"Chen","year":"2015","journal-title":"World J Pediatr"},{"key":"10.1016\/j.arcped.2025.09.002_bib0008","first-page":"259","article-title":"[Internet] Kidney disease: improving global outcomes. KDIGO clinical practice guideline for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Inter Suppl"},{"key":"10.1016\/j.arcped.2025.09.002_bib0009","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1186\/s12887-022-03709-0","article-title":"Hemoperfusion and intravenous immunoglobulins for refractory gastrointestinal involvement in pediatric Henoch-Sch\u00f6nlein purpura: a single-center retrospective cohort study","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.arcped.2025.09.002_bib0010","first-page":"1113","article-title":"Therapeutic effect of mycophenolate mofetil or cyclophosphamide in children with Henoch-Sch\u00f6nlein purpura nephritis of different age groups","volume":"25","author":"Du","year":"2023","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.arcped.2025.09.002_bib0011","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1017\/cts.2024.1050","article-title":"454 Factors influencing pharmacokinetics of tacrolimus in hematopoietic stem cell transplantation: the integration of microbiome and pharmacogenomics","volume":"9","author":"Mohamed","year":"2025","journal-title":"J Clin Transl Sci"},{"key":"10.1016\/j.arcped.2025.09.002_bib0012","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jcph.1823","article-title":"Precision dosing for tacrolimus using genotypes and clinical factors in kidney transplant recipients of european ancestry","volume":"61","author":"Al-Kofahi","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.arcped.2025.09.002_bib0013","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/archdischild-2017-313788","article-title":"Off-label use of tacrolimus in children with Henoch-Sch\u00f6nlein purpura nephritis: a pilot study","volume":"103","author":"Zhang","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.arcped.2025.09.002_bib0014","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/cpt.2451","article-title":"A proposed approach for the determination of the bioequivalence acceptance range for narrow therapeutic index drugs in the European Union","volume":"111","author":"Paix\u00e3o","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.arcped.2025.09.002_bib0015","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/j.ekir.2024.08.025","article-title":"Age-related differences in rejection rates, infections, and tacrolimus exposure in pediatric kidney transplant recipients in the CERTAIN registry","volume":"9","author":"Baghai Arassi","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.arcped.2025.09.002_bib0016","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00467-024-06502-6","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis","volume":"40","author":"Vivarelli","year":"2025","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2025.09.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/20420986241243165","article-title":"Drug-drug interaction between tacrolimus and caspofungin in Chinese kidney transplant patients with different CYP3A5 genotypes","volume":"15","author":"Zhang","year":"2024","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.arcped.2025.09.002_bib0018","first-page":"53","article-title":"Pharmacogenomic analysis of CYP3A5\u00d73 and tacrolimus trough concentrations in Vietnamese renal transplant outcomes","volume":"17","author":"Nguyen","year":"2024","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.arcped.2025.09.002_bib0019","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/10600280231190943","article-title":"Artificial neural network analysis of determinants of tacrolimus pharmacokinetics in liver transplant recipients","volume":"58","author":"Du","year":"2024","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.arcped.2025.09.002_bib0020","first-page":"738","article-title":"Interpretation of the evidence-based guidelines for the diagnosis and treatment of steroid-sensitive, relapsing\/dependent nephrotic syndrome in children (2016)","volume":"55","author":"Yang","year":"2017","journal-title":"Chin J Pediatr"},{"key":"10.1016\/j.arcped.2025.09.002_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106290","article-title":"Tacrolimus treatment in childhood refractory nephrotic syndrome: a retrospective study on efficacy, therapeutic drug monitoring, and contributing factors to variable blood tacrolimus levels","volume":"81","author":"Guo","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.arcped.2025.09.002_bib0022","series-title":"Common Terminology Criteria for Adverse Events (CTCAE)","year":"2017"},{"key":"10.1016\/j.arcped.2025.09.002_bib0023","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapediatrics.2018.1323","article-title":"Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: a randomized clinical trial","volume":"172","author":"Basu","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.arcped.2025.09.002_bib0024","doi-asserted-by":"crossref","first-page":"A42.3","DOI":"10.1136\/archdischild-2017-esdppp.93","article-title":"PP-47\u2005off-label use of tacrolimus in children with Henoch-Schonlein purpura nephritis: efficacy and safety","volume":"102","author":"Z","year":"2017","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.arcped.2025.09.002_bib0025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1159\/000097864","article-title":"Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus","volume":"26","author":"Bhimma","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.arcped.2025.09.002_bib0026","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00467-003-1370-3","article-title":"Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome","volume":"19","author":"Loeffler","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2025.09.002_bib0027","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nep.12537","article-title":"Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome","volume":"21","author":"Wang","year":"2016","journal-title":"Nephrology"},{"key":"10.1016\/j.arcped.2025.09.002_bib0028","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00467-010-1471-8","article-title":"Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus","volume":"25","author":"Roberti","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2025.09.002_bib0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/ckj\/sfv075","article-title":"A European multicentre and open-label controlled randomized trial to evaluate the efficacy of sequential treatment with tacrolimus-rituximab versus steroids plus cyclophosphamide in patients with primary membranous nephropathy: the starmen study","volume":"8","author":"Rojas-Rivera","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.arcped.2025.09.002_bib0031","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/cpt.3448","article-title":"Optimal trough concentration of tacrolimus in pediatric patients with primary nephrotic syndrome","volume":"117","author":"Wang","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.arcped.2025.09.002_bib0032","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00228-019-02781-3","article-title":"Risk factors and clinical characteristics of tacrolimus-induced acute nephrotoxicity in children with nephrotic syndrome: a retrospective case-control study","volume":"76","author":"Gao","year":"2020","journal-title":"Eer J Clin Pharmacol"},{"key":"10.1016\/j.arcped.2025.09.002_bib0033","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00467-015-3133-3","article-title":"Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome","volume":"30","author":"Jahan","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2025.09.002_bib0034","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000357355","article-title":"Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience","volume":"4","author":"Kim","year":"2014","journal-title":"Nephron Extra"},{"key":"10.1016\/j.arcped.2025.09.002_bib0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/FTD.0000000000001002","article-title":"Predictive capacity of population pharmacokinetic models for the tacrolimus dose requirements of pediatric solid organ transplant recipients","volume":"45","author":"Pasternak","year":"2023","journal-title":"Ther Drug Monit"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X25002064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X25002064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:12:38Z","timestamp":1773911558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X25002064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0929693X25002064"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2025.09.002","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus in pediatric patients with Henoch-Sch\u00f6nlein purpura nephritis: Target concentration range","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2025.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie.","name":"copyright","label":"Copyright"}],"article-number":"105444"}}